That's a far stronger title than Rett and FXS ("successful"). Looks like it's on....
Ann: Trofinetide significant clinical benefit in Rett syndrome, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$16.75 |
Change
0.270(1.64%) |
Mkt cap ! $2.114B | |||
| Open | High | Low | Value | Volume |
| $16.65 | $16.80 | $16.33 | $671.9K | 40.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 33 | $16.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.76 | 54 | 3 |
View Market Depth
| Last trade - 10.53am 29/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |